real word drugs

PreclinicalSmall molecule

real word drugs is one of 4 small molecule programs targeting Familial Mediterranean Fever. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Familial Mediterranean FeverActive, not recruiting

Familial Mediterranean FeverPreclinical

Active, not recruiting

Competition

Competitive Landscape

3 competitors in Familial Mediterranean Fever

#DrugCompanyPhaseTrials

Colcrys

Jazz Pharmaceuticals

Approved

—2

Kineret

SSwedish Orphan Biovitrum

Approved

2 3

RPH-104

UUnknown Sponsor

Phase 2

2 4

real word drugs

TTongji Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Recruiting

Familial Mediterranean Fever

NCT07077473

Clinical

Trials by Indication[1]

Familial Mediterranean Fever1 trial

Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases

Recruiting·TTongji Hospital··NCT07077473·12 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for real word drugs. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — real word drugs compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for real word drugs. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Tongji Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TTongji Hospital

real word drugs

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Familial Mediterranean Fever1 trial

References

Drug Info

Quick Facts

Related News